Zhenyu Zhao

Key Laboratory Of Molecular Biology Of Infectious Diseases
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Zinc finger protein ZBTB7A suppresses hepatitis B virus replication by attenuating FXRα-mediated HBV transcription and lowering covalently closed circular DNA levels.

Zinc finger protein ZBTB7A suppresses hepatitis B virus replication by attenuating FXRα-mediated HBV transcription and lowering covalently closed circular DNA levels.

Journal: Antiviral research

Published: February 10, 2026

RAB1A promotes hepatitis B virus replication by enhancing PPARα-mediated viral transcription and inducing ULK1-mediated autophagy.

RAB1A promotes hepatitis B virus replication by enhancing PPARα-mediated viral transcription and inducing ULK1-mediated autophagy.

Journal: International journal of biological macromolecules

Published: March 29, 2025

Hepatocyte-Enriched miRNA-193b-3p Promotes Hepatitis B Virus Replication by Dual Activation of Viral Core Promoter Activity and Autophagy Induction by Targeting IGF-1R.

Hepatocyte-Enriched miRNA-193b-3p Promotes Hepatitis B Virus Replication by Dual Activation of Viral Core Promoter Activity and Autophagy Induction by Targeting IGF-1R.

Journal: Journal of medical virology

Published: December 24, 2024

Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways.

Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways.

Journal: Emerging microbes & infections

Published: September 19, 2023

Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines.

Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines.

Journal: Emerging microbes & infections

Published: February 03, 2022

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.

Journal: Emerging microbes & infections

Published: January 06, 2022

Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects.

Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects.

Journal: Cellular & molecular immunology

Published: April 29, 2021

Realization of humoral immunity against SARS-CoV-2 infections.

Realization of humoral immunity against SARS-CoV-2 infections.

Journal: Fundamental research

Published: March 01, 2021

The interplay between emerging human coronavirus infections and autophagy.

The interplay between emerging human coronavirus infections and autophagy.

Journal: Emerging microbes & infections

Published: January 05, 2021

The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes.

The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes.

Journal: Cell discovery

Published: December 23, 2020

Interplay between Cellular Autophagy and Hepatitis B Virus Replication: A Systematic Review.

Interplay between Cellular Autophagy and Hepatitis B Virus Replication: A Systematic Review.

Journal: Cells

Published: July 02, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026